FDA Inspection
Invitrx Therapeutics Inc.FDA Inspection 1165854 - Invitrx Therapeutics Inc. - March 22, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Invitrx Therapeutics Inc., with an inspection on March 22, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
Open in Dashboard
ID · 6d1c02ea-ed52-43f5-be1c-143b4644fade
Violation Codes10
21 CFR 1271.180(a)21 CFR 1271.230(a)21 CFR 1271.265(c)(2)21 CFR 1271.50(a)21 CFR 211.100(a)21 CFR 211.101(b)21 CFR 211.110(b)21 CFR 211.113(b)21 CFR 211.160(b)21 CFR 211.166(a)
Full citation text and observation details available on the Dashboard.